Shrishrimal Sumi's Form 4 filing
Dexcom Inc (DXCM) · filed Sep 13, 2021
- Accession no.
- 0001093557-21-000219
- Filed
- Sep 13, 2021
- Trade date
- Sep 9, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $220.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shrishrimal SumiCIK 0001850687 | Officer (SVP Chief Risk Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2021 | Common Stock | SSaleDisposed | −402 | $541.36 | −$217,626.72 | 12,239 | Direct | |
| Sep 9, 2021 | Common Stock | SSaleDisposed | −5 | $542.46 | −$2,712.3 | 12,234 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.